REAfinity® Recombinant Antibody Technology

At Miltenyi Biotec, we harness cutting-edge recombinant antibody technology to provide you with antibodies that are consistent, reliable, and high-performing.

REAfinity Recombinant Antibodies combine precision, reproducibility, and ethical production, so you can focus on generating meaningful, reproducible data without the variability of traditional antibody approaches.

What are recombinant antibodies?

Plastic model of a recombinant REAfinity Antibody

Traditional antibody production involves immunizing animals, such as mice or rabbits, and collecting their blood or spleen cells to isolate the antibodies. These antibodies are usually polyclonal, representing a mixed population with varying specificities. Hybridoma technology improves upon this process by creating immortalized cell lines that produce monoclonal antibodies. However, conventional methods can result in batch variability, off-target binding, cross-reactivity, and genetic drift over time.

Recombinant antibody technology overcomes these limitations by producing antibodies through a fully defined genetic approach. DNA sequences that encode the variable regions of the antibodies are cloned into expression vectors and expressed in host cells. The result is recombinant antibodies and monoclonal antibodies that are fully characterized, reproducible, and highly reliable, giving researchers consistent performance across experiments and applications.

What are the benefits of REAfinity Recombinant Antibodies?

Logo REAfinity recombinant antibodies

REAfinity Recombinant Antibodies set a new standard for reproducibility, precision, and ease of use. Each antibody is cloned from a single, well-characterized sequence, which eliminates variability between batches. Designed for exceptional specificity, low background, and superior lot-to-lot consistency, these antibodies deliver reliable results while saving you time and reducing the need for experimental troubleshooting.

Dot plots with performance comparison: Selected fluorochrome-conjugated antibodies from Miltenyi Biotec were compared to commercially available hybridoma clones in flow cytometry analysis.
Performance comparison

Engineered for enhanced sensitivity and specificity

REAfinity Recombinant Antibodies are optimized from the most effective hybridoma antibodies, delivering unmatched sensitivity and target specificity. Each antibody is genetically designed to recognize its target with exceptional accuracy, thereby minimizing background and off-target binding. The result: clearer signals, cleaner data, and greater confidence in your experiments.

Dot plots showing no more background signal with REAfinity Recombinant Antibodies, even without FcR block.
No more background signal with REAfinity Recombinant Antibodies

Designed for simplified experiments and better results

The genetic modification of the human IgG1 Fc constant region prevents binding to Fcγ receptors (CD16, CD32, and CD64), thereby eliminating unwanted background signals. With a uniform IgG1 constant region across all REAfinity Recombinant Antibodies, multiple isotype controls are unnecessary, simplifying workflows and accelerating research.

Histogram showing lot-to-lot consistent performance of REAfinity Recombinant Antibodies
Lot-to-lot consistent performance

Reliability and reproducibility of each batch

All REAfinity Recombinant Antibodies are produced under tightly controlled conditions in our in-house facilities, ensuring batch-to-batch consistency. Every antibody is genetically defined, which guarantees reproducibility across experiments, labs, and time.

Fluorescence microscopy image of CD56 knockout cells. Wild type (WT, left) and knockout cells (KO, right) were stained with CD56-PE (REA196, red) and counterstained with DRAQ5 (blue) as DNA stain.
Knockout validation

Validated and optimized for each application

Every REAfinity Recombinant Antibody undergoes extensive validation. Methods such as knockout validation, functional testing, and lot-to-lot consistent performance confirm specificity, affirm sensitivity, and guarantee reproducibility. Together, these steps ensure optimal performance in flow cytometry, spatial biology, light sheet imaging, and mass cytometry. Using prevalidated antibodies saves you time on optimization and provides reliable, high-quality results that advance your research.

Purple Icons of the 3R-principle (Replace, Reduce, Refine) on a white background.

Animal-conscious production

REAfinity Recombinant Antibodies adhere to the 3Rs principle: replace, reduce, and refine. By eliminating the need for repeated animal immunization, reducing animal use, and improving reproducibility, this recombinant antibody technology makes research more ethical, efficient, and effective without compromising quality.

Logo of the VioDyes, fluorochromes for flow cytometry and fluorescence microscopy high fluorescence characterized by intensities and low spillover

Conjugated to a broad portfolio of fluorochromes

REAfinity Recombinant Antibodies are available with an extensive range of Vio® and Vio Bright Dye fluorochromes. This allows for larger, more powerful panels in multiplexed experiments, providing brighter, clearer signals and expanded analytical possibilities.

The Miltenyi Biotec way of generating best-in-class antibodies and antibody conjugates

REAfinity Recombinant Antibodies are developed by combining genetic material from immunized animals and screening in-house antibody libraries to identify the most effective antibodies. Reverse engineering of existing hybridoma-based antibodies can further produce novel, optimized sequences for superior performance.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015)). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Our highly defined recombinant antibodies will take your experiment to the next level.

Maximizing value for your research

By re-engineering antibody sequences, we precisely control properties to:

  • reduce unwanted binding to Fc gamma receptors,
  • eliminate destabilizing amino acid motifs,
  • increase specific binding affinity for accurate targeting,
  • optimize fluorochrome conjugation for brighter, clearer signals.

The resulting gene sequence is cloned into an expression vector, producing a cell line that generates a highly defined recombinant antibody.

Icon depicting two shaking hands with the text "satisfaction guaranteed"

Your satisfaction matters

Every Miltenyi Biotec reagent is quality-checked to ensure reliable, consistent results. We know how important it is to be sure of the quality of reagents when you start an experiment. This is why we carry out strict quality control on all reagent batches. You can be assured that all reagents leave our production facilities in the best quality and condition.

Resources

REAfinity Recombinant Antibody logo combined with a quality sign
Background information

REAfinity Recombinant Antibody production

Dive deep into our standardized, fully traceable production workflow that provides you with antibodies you can truly trust.

Flow cytometry tools

Fluorescence spectra viewer

Analyze the spectral signatures of your fluorochromes to avoid spillover.

Top view on antibody vials with color-coded lids placed in rows
Flow cytometry tools

Multicolor flow cytometry panel builder

Design complex multicolor panels with optimized antibody choices, tailored to your experimental setup.

All REAfinity Recombinant Antibodies

1212 products found

|

You have previously chosen International as your location.
What do you want to do?